These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38989943)

  • 1. New glucocerebrosidase antibodies can advance research in the field of neurodegenerative disorders.
    Ma C; Rytel K; Chen Y; Sidransky E
    Neural Regen Res; 2025 Apr; 20(4):1085-1086. PubMed ID: 38989943
    [No Abstract]   [Full Text] [Related]  

  • 2. GBA1 inactivation in oligodendrocytes affects myelination and induces neurodegenerative hallmarks and lipid dyshomeostasis in mice.
    Gregorio I; Russo L; Torretta E; Barbacini P; Contarini G; Pacinelli G; Bizzotto D; Moriggi M; Braghetta P; Papaleo F; Gelfi C; Moro E; Cescon M
    Mol Neurodegener; 2024 Mar; 19(1):22. PubMed ID: 38454456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of anti-glucocerebrosidase antibodies for western blot analysis on protein lysates of murine and human cells.
    Qi W; Davidson BA; Nguyen M; Lindstrom T; Grey RJ; Burnett R; Aflaki E; Sidransky E; Westbroek W
    Biochem J; 2019 Jan; 476(2):261-274. PubMed ID: 30578288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency.
    Gatto EM; Da Prat G; Etcheverry JL; Drelichman G; Cesarini M
    Brain Sci; 2019 Feb; 9(2):. PubMed ID: 30717266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Antibodies to Advance Glucocerebrosidase Research.
    Dzamko N
    J Parkinsons Dis; 2024; 14(1):79-80. PubMed ID: 38251065
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucocerebrosidase is shaking up the synucleinopathies.
    Siebert M; Sidransky E; Westbroek W
    Brain; 2014 May; 137(Pt 5):1304-22. PubMed ID: 24531622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
    Blanz J; Saftig P
    J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocerebrosidase and its relevance to Parkinson disease.
    Do J; McKinney C; Sharma P; Sidransky E
    Mol Neurodegener; 2019 Aug; 14(1):36. PubMed ID: 31464647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher disease: a lysosomal neurodegenerative disorder.
    Huang WJ; Zhang X; Chen WW
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1219-26. PubMed ID: 25912581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the two immunologically distinguishable forms of glucocerebrosidase in tissue extracts.
    Aerts JM; Donker-Koopman WE; van Laar C; Brul S; Murray GJ; Wenger DA; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1987 Mar; 163(3):583-9. PubMed ID: 3830174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocerebrosidase dysfunction in neurodegenerative disease.
    Brooker SM; Krainc D
    Essays Biochem; 2021 Dec; 65(7):873-883. PubMed ID: 34528667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Glucocerebrosidase Dysfunction in Parkinson's Disease.
    Chatterjee D; Krainc D
    J Mol Biol; 2023 Jun; 435(12):168023. PubMed ID: 36828270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant β-Glucocerebrosidase specific immunoaffinity ligands selected from phage-displayed combinatorial scFv libraries.
    Anisimov RL; Ershova OA; Ershov AV; Filatova MA; Katorkin SA; Simonov VM
    Protein Expr Purif; 2020 Jun; 170():105573. PubMed ID: 31981620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
    Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
    J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive decline of glucocerebrosidase in aging and Parkinson's disease.
    Rocha EM; Smith GA; Park E; Cao H; Brown E; Hallett P; Isacson O
    Ann Clin Transl Neurol; 2015 Apr; 2(4):433-8. PubMed ID: 25909088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assignment of the gene coding for human beta-glucocerebrosidase to the region q21-q31 of chromosome 1 using monoclonal antibodies.
    Barneveld RA; Keijzer W; Tegelaers FP; Ginns EI; Geurts van Kessel A; Brady RO; Barranger JA; Tager JM; Galjaard H; Westerveld A; Reuser AJ
    Hum Genet; 1983; 64(3):227-31. PubMed ID: 6885065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders.
    Goker-Alpan O; Stubblefield BK; Giasson BI; Sidransky E
    Acta Neuropathol; 2010 Nov; 120(5):641-9. PubMed ID: 20838799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle.
    Sardi SP; Cheng SH; Shihabuddin LS
    Prog Neurobiol; 2015 Feb; 125():47-62. PubMed ID: 25573151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson's Disease Patient Monocytes and Inversely Correlates with Motor Severity.
    Hughes LP; Pereira MMM; Hammond DA; Kwok JB; Halliday GM; Lewis SJG; Dzamko N
    J Parkinsons Dis; 2021; 11(3):1157-1165. PubMed ID: 33935104
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.